Skip to content

Effect of dexmedetomidine combined with cognitive behavioral therapy on chronic insomnia

Effect of dexmedetomidine combined with cognitive behavioral therapy on chronic insomnia

Status
Unknown
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067488
Enrollment
Unknown
Registered
2023-01-10
Start date
2023-01-10
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia disorder

Interventions

CBT-I group:8 weeks of CBTI coaching
Dex+CBTI group:Dextrmedetomidine intravenous pumping and 8 weeks of CBTI coaching

Sponsors

Shanghai Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. Meet the ICSD-3 diagnostic criteria for chronic insomnia; 3. Received routine internal medicine treatment with poor results; 4. Be able to understand and cooperate in completing the Sleep diary and assessment questionnaire; 5. Voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of hypertension, Hypotension and bradycardia; 2. Heart, lung, liver, and kidney dysfunction; 3. Uncontrolled anxiety, depression, and/or mental disorders; 4. Hearing impairment, dysarthria, cognitive impairment; 5. Sleep apnea Hypopnea syndrome, restless legs syndrome and other Sleep disorder; 6. Pregnancy or lactation period.

Design outcomes

Primary

MeasureTime frame
Insomnia severity index;CBT-I completion rate;Polysomnography;

Secondary

MeasureTime frame
epworth sleepiness scale;Fatigue Severity Scale;Hospital anxiety and depression;

Countries

China

Contacts

Public ContactLi Qingfang

Shanghai Fourth People's Hospital

170372602@qq.com+86 136 7183 4019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026